Free Trial

Iberia Capital's Rating of Core Laboratories on 5/12/2014

On May 12, 2014, Iberia Capital updated its outlook on Core Laboratories (NYSE:CLB) with the action "Downgrade", setting a "Sector Perform" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.